Skip to content

Effects of profile on patient tolerance during hemodialysis

Effects of linear sodium - ultrafiltration profile on patient tolerance during hemodialysis, in Hemodialysis patients Hamadan's Besat Hospital 1392.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013072814194N1
Enrollment
30
Registered
2013-08-26
Start date
2013-08-30
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodialysis patient. End stage kidney disease:on dialysis

Interventions

Intervention 1: In this study, the typical profile of linear sodium - ultrafiltration is performed . Purpose of linear sodium dialysate is sodium dialysate during the hours of the first treatment, dia
Prevention
In this study, the typical profile of linear sodium - ultrafiltration is performed . Purpose of linear sodium dialysate is sodium dialysate during the hours of the first treatment, dialysis, 146 mmol/
In the example that was made ??to the profile , the dialysis procedure is performed . During the procedure, the dialysate sodium concentration of 138 mmol l first and last dialysis treatment on the ul

Sponsors

Vice chancellor for research & technology, Hamadan university of medical sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria for this study included : Patients 18-75 years old ; Over 3 months of hemodialysis; 1-4 kg weight gain between dialysis ; Patients with end-stage renal disease ; Dialysis two or three times a week with a solution of sodium bicarbonate should be done; No night predialysis blood pressure -lowering drugs are not used ; Heart disease - specific diseases such as heart muscle death or have a pacemaker ; With severe anemia (Hb <8) do not ; According to medical diabetic neuropathy (due to orthostatic hypotension in these patients ) are not. Exclusion criteria : Heart and lung disorders; unstable heart muscle death and during dialysis ; Lack of patient cooperation ; Low blood pressure is high enough to lead to discontinuation of dialysis ; if Anti hypertensive drugs in patients on dialysis or had consumed the night before, or before a dialysis session should eat foods high in volume, it is not the meeting to analyze the data; Hypertensive patients after transfusion of blood and other solutions will not increase blood volume analysis .

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Blood pressure. Timepoint: Before hemodialysis, the first , second, third and fifth minutes after hemodialysis. Method of measurement: Mercury manometer.;Muscle Cramp. Timepoint: Before hemodialysis, the first , second, third and fifth minutes after hemodialysis. Method of measurement: Visual Analog Scale.;Comfort. Timepoint: After each dialysis session. Method of measurement: Visual Comfort Scale Kolkaba.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAzam Farmani

Hamadan university of medical sciences

A.farmani@umsha.ac.ir,Azamfarmani@ymail.com008372226045

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026